Macrophage Role in the Anti-Prostate Cancer Response to One Class of Antiangiogenic Agents
Data up to Jan 2025
Total Citations Per Year
Abstract
References (39)
Angiogenesis in cancer, vascular, rheumatoid and other disease
1995 • 7,717 citations
Patterns and Emerging Mechanisms of the Angiogenic Switch during Tumorigenesis
1996 • 6,878 citations
Vaccination with irradiated tumor cells engineered to secrete murine granulocyte-macrophage colony-stimulating factor stimulates potent, specific, and long-lasting anti-tumor immunity.
1993 • 2,828 citations
Thalidomide is an inhibitor of angiogenesis.
1994 • 2,460 citations
Clinical Cancer Research
1941 • 1,358 citations
Macrophages and angiogenesis
1994 • 1,123 citations
Thalidomide exerts its inhibitory action on tumor necrosis factor alpha by enhancing mRNA degradation.
1993 • 1,058 citations
Regulators of Angiogenesis
1991 • 959 citations
Genistein, a dietary-derived inhibitor of in vitro angiogenesis.
1993 • 777 citations
Human interferon-inducible protein 10 is a potent inhibitor of angiogenesis in vivo.
1995 • 710 citations
Programmed cell death during regression of PC-82 human prostate cancer following androgen ablation.
1990 • 485 citations
Vascular Endothelial Cell Growth Factor Promotes Tyrosine Phosphorylation of Mediators of Signal Transduction That Contain SH2 Domains
1995 • 480 citations
Effects of Thalidomide and Related Metabolites in a Mouse Corneal Model of Neovascularization
1997 • 447 citations
Establishment and characterization of seven dunning rat prostatic cancer cell lines and their use in developing methods for predicting metastatic abilities of prostatic cancers
1986 • 412 citations
The Molecular Basis of Cancer
1985 • 389 citations
Induction of neovascularization in vivo and endothelial proliferation in vitro by tumor-associated macrophages.
1984 • 366 citations
Urokinase-type plasminogen activator is induced in migrating capillary endothelial cells.
1987 • 286 citations
Androgens regulate vascular endothelial growth factor content in normal and malignant prostatic tissue.
1997 • 215 citations
Prognostic value of urokinase-type plasminogen activator (uPA) and plasminogen activator inhibitors PAI-1 and PAI-2 in breast carcinomas
1994 • 159 citations
Lipopolysaccharide‐induced cytokine production in human monocytes: Role of tyrosine phosphorylation in transmembrane signal transduction
1994 • 158 citations
IL-12 regulates VEGF and MMPs in a murine breast cancer model
1998 • 138 citations
Alterations of the p53 tumor suppressor gene and its association with activation of the c-K-ras-2 protooncogene in premalignant and malignant lesions of the human uterine endometrium.
1993 • 131 citations
Inhibition of cancer cell urokinase plasminogen activator by its specific inhibitor PAI-2 and subsequent effects on extracellular matrix degradation.
1990 • 112 citations
Plasminogen activator inhibitor-2: prognostic relevance in 1012 patients with primary breast cancer.
1995 • 106 citations
Antiangiogenic effects of the quinoline-3-carboxamide linomide.
1993 • 104 citations
Potentiation of the antiangiogenic ability of linomide by androgen ablation involves down-regulation of vascular endothelial growth factor in human androgen-responsive prostatic cancers.
1997 • 102 citations
Linomide inhibits angiogenesis, growth, metastasis, and macrophage infiltration within rat prostatic cancers.
1995 • 99 citations
Plasminogen activator system in human breast cancer
1992 • 78 citations
Antiangiogenic treatment with linomide as chemoprevention for prostate, seminal vesicle, and breast carcinogenesis in rodents.
1996 • 57 citations
Human prostatic cancer cells are sensitive to programmed (apoptotic) death induced by the antiangiogenic agent linomide.
1995 • 56 citations
The antitumor effects of the quinoline-3-carboxamide linomide on Dunning R-3327 rat prostatic cancers.
1992 • 56 citations
Urokinase Plasminogen Activator Induces Angiogenesis and Tumor Vessel Invasion in Breast Cancer
1995 • 44 citations
Inhibition of tumor angiogenesis and the therapeutic ability of linomide against rat prostatic cancers
1995 • 40 citations
Macrophage colony-stimulating factor and granulocyte-macrophage colony- stimulating factor stimulate the synthesis of plasminogen-activator inhibitors by human monocytes
1993 • 37 citations
Anti-Angiogenic Treatment with Linomide as Adjuvant to Surgical Castration in Experimental Prostate Cancer
1997 • 27 citations
The effect of linomide on the migration and the proliferation of capillary endothelial cells elicited by vascular endothelial growth factor
1996 • 20 citations
Studies on tumor induced angiogenesis
1992 • 17 citations
The antiangiogenic agent linomide inhibits tumor necrosis factor-α secretion via inhibition of its synthesis
1996 • 16 citations
Production of plasminogen activator inhibitor type-2 in human peripheral blood monocytes upregulated in vitro by the quinoline-3-carboxamide, Linomide
1996 • 6 citations
Cited By (0)
No citing papers found in database